Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma

Phase 2 Recruiting 108 enrolled Sun Yat-sen University

RandomizedParallel-groupOpen-labelTreatment

Summary

This study is conducted to evaluate the safety and efficiency of Penpulimab combined with AVD in patients with newly- diagnosed advanced classic Hodgkin lymphoma.

Timeline

Start: 2023-10-01
Primary completion: 2026-09-30
Completion: 2027-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Penpulimab	Monoclonal antibody	—	—

Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma

Summary

Timeline

Drugs

Indications